Brain Trust Bio

Brookhaven, United States Founded: 2019 • Age: 7 yrs
Provider of contract based drugs delivery services for CNS disorders
Request Access

About Brain Trust Bio

Brain Trust Bio is a company based in Brookhaven (United States) founded in 2019 by Chen Benkler and Nicholas M Boulis.. Brain Trust Bio has raised $400 thousand across 1 funding round. Brain Trust Bio offers products and services including Continuous Intrathecal Drug Delivery Method. Brain Trust Bio operates in a competitive market with competitors including Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.

  • Headquarter Brookhaven, United States
  • Founders Chen Benkler, Nicholas M Boulis
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $400 K (USD)

    in 1 rounds

  • Latest Funding Round
    $400 K (USD), Seed

    Mar 19, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Brain Trust Bio

Brain Trust Bio offers a comprehensive portfolio of products and services, including Continuous Intrathecal Drug Delivery Method. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Administers drugs directly to CNS for enhanced efficacy and safety.

People of Brain Trust Bio
Headcount 1-10
Employee Profiles 4
Board Members and Advisors 3
Employee Profiles
People
Ali Almuzaini
Business Development & Strategy
People
Nicholas M. Boulis
Chief Scientific Officer
People
Chen Benkler
Co-Founder & CEO
People
Lynn Scott
Legal Counsel

Unlock access to complete

Board Members and Advisors
people
Robert Bowser
Chairman
people
Yue Chen
Scientific Advisor
people
Nicholas John Maragakis
Scientific Advisor

Unlock access to complete

Funding Insights of Brain Trust Bio

Brain Trust Bio has successfully raised a total of $400K through 1 strategic funding round. The most recent funding activity was a Seed round of $400 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $400,000
  • First Round

    (19 Mar 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2021 Amount Seed - Brain Trust Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Brain Trust Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Brain Trust Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Brain Trust Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Brain Trust Bio

Brain Trust Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosimulation technology is provided for CNS drug discovery and development.
domain founded_year HQ Location
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
domain founded_year HQ Location
Preclinical services to neurological science are provided.
domain founded_year HQ Location
Preclinical CRO services for neurodegenerative diseases are offered by Neuro-Sys.
domain founded_year HQ Location
Provides preclinical services in behavioral pharmacology for research and development.
domain founded_year HQ Location
Provider of in vivo and ex vivo services to drug developers for neurological disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Brain Trust Bio

Frequently Asked Questions about Brain Trust Bio

When was Brain Trust Bio founded?

Brain Trust Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Brain Trust Bio located?

Brain Trust Bio is headquartered in Brookhaven, United States. It is registered at Brookhaven, Mississippi, United States.

Who is the current CEO of Brain Trust Bio?

Chen Benkler is the current CEO of Brain Trust Bio. They have also founded this company.

Is Brain Trust Bio a funded company?

Brain Trust Bio is a funded company, having raised a total of $400K across 1 funding round to date. The company's 1st funding round was a Seed of $400K, raised on Mar 19, 2021.

What does Brain Trust Bio do?

Brain Trust Bio, based in Brookhaven, focuses on providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and neurology. Provider of contract based drugs delivery services for CNS disorders. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of Brain Trust Bio?

Brain Trust Bio's top competitors include Brains On-Line, Neuro-Sys and Rhenovia Pharma.

What products or services does Brain Trust Bio offer?

Brain Trust Bio offers Continuous Intrathecal Drug Delivery Method.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available